山东大学学报 (医学版) ›› 2022, Vol. 60 ›› Issue (2): 121-124.doi: 10.6040/j.issn.1671-7554.0.2021.0420
• 病例报道 • 上一篇
张文红1,王翠翠2,王小康1,张君1,郝薇1
中图分类号:
| [1] Saleem AF, Qamar FN, Shahzad H, et al. Trends in antibiotic susceptibility and incidence of late-onset Klebsiella pneumoniae neonatal sepsis over a six-year period in a neonatal intensive care unit in Karachi, Pakistan[J]. Int J Infect Dis, 2013, 17(11): 961-965. [2] Gupta S, Govil D, Kakar PN, et al. Colistin and polymyxin B: a re-emergence[J]. Indian J Crit Care Med, 2009, 13(2): 49-53. [3] Thomas R, Velaphi S, Ellis S, et al. The use of polymyxins to treat carbapenem resistant infections in neonates and children [J]. Expert Opin Pharmacother, 2019, 20(4): 415-422. [4] 中华医学会儿科学分会新生儿学组,中国医师协会新生儿科医师分会感染专业委员会. 新生儿败血症诊断及治疗专家共识(2019年版)[J].中华儿科杂志,2019, 57(4): 252-257. [5] 杨素艳,孙夫强,段洋.早发型败血症早产儿脐血培养价值研究[J].中国全科医学,2020,23(27): 3422-3426. YANG Suyan, SUN Fuqiang, DUAN Yang. The value of umbilical cord blood culture in premature infants with early-onset sepsis [J].Chinese General Practice, 2020, 23(27): 3422-3426. [6] Puopolo KM, Benitz WE, Zaoutis TE, et al. Management of neonates born at ≤34 6/7 weeks' gestation with suspected or proven early-onset bacterial sepsis[J]. Pediatrics, 2018, 142(6): e20182896. [7] 李正红,王丹华.新生儿早发型败血症的临床特点[J].中华围产医学杂志, 2011,14(7): 420-424. [8] Shane AL, Sánchez PJ, Stoll BJ. Neonatal sepsis[J]. Lancet, 2017, 390(10104): 1770-1780. [9] 张武栋.早产儿及足月儿新生儿败血症临床特征比较[J]. 中国卫生标准管理, 2020,11(18): 36-38. [10] 袁莹,杨颖.多黏菌素B和E:如何选择[J].中国感染控制杂志,2017, 16(7): 677-682. [11] Richards M, Thursky K, Buising K. Epidemiology, prevalence, and sites of infections in intensive care units[J]. Semin Respir Crit Care Med, 2003, 24(1): 3-22. [12] Ylipalosaari P, Ala-Kokko TI, Laurila J, et al. Intensive care acquired infection is an independent risk factor for hospital mortality: a prospective cohort study[J]. Crit Care, 2006, 10(2): R66. [13] Piparsania S, Rajput N, Bhatambare G. Intraventricular polymyxin B for the treatment of neonatal meningo-ventriculitis caused by multi-resistant Acinetobacter baumannii-case report and review of literature[J]. Turk J Pediatr, 2012, 54(5): 548-554. [14] Al-Lawama M, Aljbour H, Tanash A, et al. Intravenous Colistin in the treatment of multidrug-resistant Acinetobacter in neonates[J]. Ann Clin Microbio Antimicrob, 2016, 15: 8. doi: 10.1186/s12941-016-0126-4. [15] Zakuan ZD, Suresh K. Rational use of intravenous polymyxin B and colistin: a review[J]. Med J Malaysia, 2018, 73(5): 351-359. [16] Rigatto MH, Oliveira MS, Perdigão-Neto LV, et al. Multicenter prospective cohort study of renal failure in patients treated with colistin versus polymyxin B[J]. Antimicrob Agents Chemother, 2016, 60(4): 2443-2449. [17] Phe K, Lee Y, McDaneld PM, et al. In vitro assessment and multicenter cohort study of comparative nephrotoxicity rates associated with colistimethate versus polymyxin B therapy[J]. Antimicrob Agents Chemother, 2014, 58(5): 2740-2746. [18] Kelesidis T, Falagas ME. The safety of polymyxin antibiotics[J]. Expert Opin Drug Saf, 2015, 14(11): 1687-1701. [19] Zavascki AP, Manfro RC, Maciel RA, et al. Head and neck hyperpigmentation probably associated with polymyxin B therapy[J]. Ann Pharmacother, 2015, 49(10): 1171-1172. [20] Gothwal S, Meena K, Sharma SD. Polymyxin B induced generalized hyperpigmentation in neonates[J]. Indian J Pediatr, 2016, 83(2): 179-180. |
| [1] | 李娅,袁鹏,张飞雪,邵广瑞. 肺脏超声在肺表面活性物质治疗早产儿呼吸窘迫综合征中的评价作用[J]. 山东大学学报 (医学版), 2018, 56(2): 34-40. |
| [2] | 仇杰,臧丽娇,庄根苗,安丽. 不同胎龄围生期窒息与多器官功能损伤的相关性[J]. 山东大学学报（医学版）, 2016, 54(9): 64-68. |
| [3] | 慈春燕，李文，卢宪梅. 早产儿早期振幅整合脑电图特点的分析[J]. 山东大学学报(医学版), 2012, 50(9): 109-112. |
| [4] | 成锴1,2，张林娜1，孙明2，侯茜2，张敏2，杨海霞2. 773例早产儿视网膜病变筛查结果分析[J]. 山东大学学报(医学版), 2011, 49(9): 149-152. |
| [5] | 杨学勇1，周更须1，李秋平2，付松1，刘宇航1，王辉1，赵鑫2，封志纯3. 早产儿动脉导管未闭的床旁外科治疗[J]. 山东大学学报(医学版), 2011, 49(8): 133-135. |
| [6] | 吴巧灵,孙正芸,林霞. 早产儿血清碱性磷酸酶、钙、磷的代谢特点[J]. 山东大学学报(医学版), 2010, 48(2): 113-. |
|
